Loading data
XYLNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.04 bn USD | 8.56 bn USD | 7.36 bn USD | 5.52 bn USD | 5.2 bn USD |
| Cost of revenue | 5.56 bn USD | 5.35 bn USD | 4.65 bn USD | 3.44 bn USD | 3.22 bn USD |
| Gross profit | 3.48 bn USD | 3.21 bn USD | 2.72 bn USD | 2.08 bn USD | 1.98 bn USD |
| Research and development expense | 226 m USD | 230 m USD | 232 m USD | 206 m USD | 204 m USD |
| Selling, general and administrative expense | 1.92 bn USD | 1.91 bn USD | 1.76 bn USD | 1.23 bn USD | 1.18 bn USD |
| Operating profit | 1.22 bn USD | 1.01 bn USD | 652 m USD | 622 m USD | 585 m USD |
| Interest expense | — | — | 49 m USD | 50 m USD | 76 m USD |
| Income tax expense | 231 m USD | 197 m USD | 26 m USD | 85 m USD | 84 m USD |
| Net income (reported basis) | 957 m USD | 890 m USD | 609 m USD | 355 m USD | 427 m USD |
| Basic earnings per share | 3.93 USD/share | 3.67 USD/share | 2.81 USD/share | 1.97 USD/share | 2.37 USD/share |
| Diluted earnings per share | 3.92 USD/share | 3.65 USD/share | 2.79 USD/share | 1.96 USD/share | 2.35 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.